Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2026"

About this update from Enveric Biosciences, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/72dc7968895ebf140b57ea22ecab3a43"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ogehqH4h3nJMG7no8fWx2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/72dc7968895ebf140b57ea22ecab3a43","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/JC5ehUrVXT8hawtnFYuQWg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/72dc7968895ebf140b57ea22ecab3a43","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Management to meet with investors and potential partners during Biotech Showcase 2026","length":85,"tagName":"p","attribs":{}},{"type":"text","content":"CAMBRIDGE, Mass., December 04, 2025--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that the company will present and participate in the Sachs Associates 9th Annual Neuroscience Innovation Forum on January 11, 2026 during "J.P. Morgan Week 2026" in San Francisco. Additionally, Enveric will attend Biotech Showcase 2026, which is being held from January 12-14, 2026.","length":583,"tagName":"p"},{"type":"text","content":"During the events, members of Enveric’s management team will conduct one-on-one meetings with registered investors and potential partners, showcasing the company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.","length":266,"tagName":"p"},{"type":"text","content":"Details are as follows:","length":23,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;width:20%;","val":[{"type":"text","content":"Event:","length":6,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;...

More updates from Enveric Biosciences, Inc.